Is macrobid (nitrofurantoin) safe for treating an uncomplicated urinary tract infection in a pregnant woman during the first trimester, assuming no G6PD deficiency, normal renal function, and no hypersensitivity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Macrobid (Nitrofurantoin) Safe in the First Trimester?

Nitrofurantoin is recommended as the first-line antibiotic for treating UTIs during the first trimester of pregnancy, with excellent safety data and no evidence of teratogenicity. 1

Primary Recommendation

The European Urology guidelines explicitly recommend nitrofurantoin (50-100 mg four times daily for 5-7 days) as first-line therapy for UTIs in the first trimester of pregnancy. 1 This recommendation is based on:

  • Decades of clinical use with no demonstrated teratogenic effects 2, 3
  • A retrospective analysis of 91 pregnancies treated with nitrofurantoin macrocrystals showed no drug-related abnormal events, with outcomes comparable to the general U.S. population 2
  • Animal studies in rats and rabbits at doses 2-6 times the human therapeutic dose demonstrated no adverse effects on maternal health, fetal development, or neonatal survival 3

Important Context on Conflicting Guidance

There is a notable discrepancy between older U.S. guidance and current international recommendations:

  • A 2011 ACOG committee opinion suggested caution with nitrofurantoin in the first trimester due to potential birth defect concerns 4
  • However, the most recent European Urology guidelines (reflected in current practice) explicitly recommend nitrofurantoin as first-line therapy for first trimester UTIs 1
  • The theoretical concerns about birth defects have not been substantiated in clinical practice or large-scale studies 2

Treatment Specifics

For symptomatic UTI in the first trimester:

  • Nitrofurantoin 50-100 mg four times daily for 7 days 1
  • Always obtain urine culture before initiating treatment 1
  • Treatment duration should be 7-14 days to ensure complete eradication 1

Fosfomycin trometamol (3g single dose) is an acceptable alternative if nitrofurantoin cannot be used 1

Critical Contraindications and Cautions

Nitrofurantoin is absolutely contraindicated:

  • At term (last trimester/near delivery) due to risk of neonatal hemolytic anemia 5, 6
  • In patients with any degree of renal impairment 6
  • In patients with known G6PD deficiency, though the actual risk appears lower than previously thought (only 42 confirmed cases of hemolysis out of 245 million exposures) 5

Antibiotics to Avoid in First Trimester

Do not use trimethoprim-sulfamethoxazole in the first trimester due to established teratogenic effects (neural tube defects, cardiac malformations) 1

Fluoroquinolones must be avoided throughout all trimesters due to potential adverse effects on fetal cartilage development 1

Clinical Urgency

The decision to treat should not be delayed:

  • Untreated bacteriuria increases pyelonephritis risk 20-30 fold (from 1-4% to 20-35%) 1
  • Treatment reduces premature delivery and low birth weight 1
  • Even asymptomatic bacteriuria must be treated during pregnancy—this is the one clinical scenario where treatment is mandatory 1

Common Pitfalls to Avoid

  • Do not withhold nitrofurantoin in the first trimester based on outdated concerns—current guidelines support its use 1
  • Do not use nitrofurantoin for suspected pyelonephritis—it does not achieve therapeutic blood concentrations; use cephalosporins instead 1
  • Do not rely on dipstick testing alone—it has only 50% sensitivity for bacteriuria in pregnancy; always obtain culture 1
  • Do not prescribe nitrofurantoin if the patient is near term or has any renal impairment 5, 6

References

Guideline

Treatment of UTI During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

[Nitrofurantoin--clinical relevance in uncomplicated urinary tract infections].

Medizinische Monatsschrift fur Pharmazeuten, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.